# Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

> **NCT01481259** · PHASE2,PHASE3 · UNKNOWN · sponsor: **People's Hospital of Guangxi Zhuang Autonomous Region** · enrollment: 120 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Autologous cytokine-induced killer cell
- **OTHER:** Pemetrexed

## Key facts

- **NCT ID:** NCT01481259
- **Lead sponsor:** People's Hospital of Guangxi Zhuang Autonomous Region
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481259, "Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01481259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*